
CTKB
Cytek Biosciences
$4.53
−$0.20 (−4.23%)Sep 10, 2026
Key metrics
The numbers that frame CTKB today
- Market cap
- $588.82M
- P/E (TTM)
- -7.3
- EV / FCF
- -44.1
- Gross margin
- 53.2%
- EV / Sales
- 2.6
- ROIC
- -14.6%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $3.28
- 52wk High
- $6.18
Growth
Revenue and earnings trend for CTKB
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CTKB
Is Cytek Biosciences a good buy?
Hold. Cytek Biosciences has mixed quality and strong momentum. The setup is mixed. Growth looks weak. That could put pressure on the long-term business case. We think Cytek Biosciences is selling at a high price.
What is the market capitalization of CTKB?
Cytek Biosciences's market capitalization is $588.82M.
What is the P/E ratio for CTKB stock?
Cytek Biosciences's current P/E ratio is -7.3.
What is the 52-week high for CTKB stock?
The 52-week high for Cytek Biosciences is $6.18. The current close of $4.53 is 26.7% below that high.
What is the 52-week low for CTKB stock?
The 52-week low for Cytek Biosciences is $3.28. The current close of $4.53 is 38.1% above that low.
Does CTKB stock pay dividends?
Cytek Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CTKB?
Cytek Biosciences's Debt / Equity ratio is 0.04.